CD163 and invasive carcinoma: To investigate the extent to which bone marrow-derived macrophages were present in human tumor or non-tumor tissues, we performed a chimerism analysis of CD163(+) cells in three cases of invasive carcinoma that developed 3.6–19.8 years after bone marrow transplantation.